Implantable Cardioverter Defibrillator Efficacy and Chronic Kidney Disease: Competing Risks of Arrhythmic and Nonarrhythmic Mortality
J Cardiovasc Electrophysiol, Vol. 19, pp. 1281–1283, December 2008.
Dr. Moss is the recipient of a research grant from Boston Scientific for the MADIT-II trial.
Address for correspondence: Ilan Goldenberg, M.D., Heart Research Follow-Up Program, University of Rochester Medical Center, Box 653, Rochester, NY 14642, USA. Fax: 585-273-5283; E-mail: email@example.com
No abstract is available for this article.